Skip navigation
mobile search icon

Governance

Clinical Trials Ontario is an independent not-for-profit organization established with support from the Ontario Government. We have strong governance from an effective Board of Directors dedicated to advancing patient care while serving the interests of government, industry, clinicians, patients and other stakeholders.

Board of Directors

CTO is proud to have a committed Board of Directors with diverse experiences in the life sciences sector.

Raphael Hofstein

Chair
Former President and Chief Executive Officer
of Toronto Innovation Acceleration Partners (TIAP)

Dr. Bradly Wouters

Vice-Chair and Secretary
Executive VP, Science & Research University Health Network

Bev Heim-Myers

Treasurer
Chair
Canadian Coalition for Genetic Fairness

Tina Ceroni

Clinical Trial Participant

Anne Ellis

Associate Professor and Chair, Division of Allergy & Immunology,
Department of Medicine, Queen’s University

James Wilson

President
Brancorth Medical Inc.

Kym Boycott

Clinician Scientist, CHEO Research Institute; Professor of Pediatrics, University of Ottawa; Tier 1 Canada Research Chair in Rare Disease Precision Health

Mark Lundie, PhD

Vice President & Global Medical Lead, Rare Endocrinology and Neurology, Pfizer Inc

Clive Ward-Able

President, Clintell Inc. 

back to top